Viewing Study NCT00570635


Ignite Creation Date: 2025-12-24 @ 10:06 PM
Ignite Modification Date: 2026-01-10 @ 2:50 PM
Study NCT ID: NCT00570635
Status: COMPLETED
Last Update Posted: 2013-06-07
First Post: 2007-12-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2 Study of XL820 in Adults With Advanced GIST Resistant to Imatinib and/or Sunitinib
Sponsor: Exelixis
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module